WO2025237418 - SALT AND CRYSTAL FORM OF CDK2 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/237418
Publication Date
20.11.2025
International Application No.
PCT/CN2025/095535
International Filing Date
16.05.2025
Title **
[English]
SALT AND CRYSTAL FORM OF CDK2 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF
[French]
SEL ET FORME CRISTALLINE D'UN INHIBITEUR DE CDK2, LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION
[Chinese]
一种CDK2抑制剂的盐、晶型及其制备方法和应用
Applicants **
SHANDONG LUYE PHARMACEUTICAL CO., LTD.
Inventors
LIU, Huifeng
LIAO, Wensheng
SUN, Runzhi
QU, Hao
WU, Yanhua
WANG, Guanghui
Priority Data
202410614141.6
17.05.2024
CN
202410971878.3
19.07.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1934 | |
| EPO | Filing, Examination, Granting | 12537 | |
| Japan | Filing, Examination, Granting | 2186 | |
| South Korea | Filing, Examination, Granting | 2237 | |
| USA | Filing, Examination, Granting | 10140 |
Total:
29,034
Contact Us
Abstract[English]
The present invention relates to a salt and a crystal form of a CDK2 inhibitor, and a preparation method therefor and the use thereof. Specifically, provided are a salt and a crystal form of a compound of formula I, a preparation method therefor, and the use thereof in the preparation of a drug for preventing or treating CDK2-mediated related diseases.[French]
La présente invention concerne un sel et une forme cristalline d'un inhibiteur de CDK2, leur procédé de préparation et leur utilisation. Plus particulièrement, l'invention concerne un sel et une forme cristalline d'un composé de formule I, leur procédé de préparation et leur utilisation dans la préparation d'un médicament pour la prévention ou le traitement de maladies associées à une médiation par CDK2.[Chinese]
本发明涉及一种CDK2抑制剂的盐、晶型及其制备方法和应用。具体而言，提供了式I化合物的盐、晶型、制备方法，以及在制备预防或治疗CDK2介导的相关疾病的药物中的应用。